Super-Responders in Patients With Moderate-to-Severe Crohn's Disease Treated With Subcutaneous Infliximab Maintenance Therapy: A Post Hoc Analysis of the LIBERT Y-CD Study.
{"title":"Super-Responders in Patients With Moderate-to-Severe Crohn's Disease Treated With Subcutaneous Infliximab Maintenance Therapy: A Post Hoc Analysis of the LIBERT Y-CD Study.","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"20 7 Suppl 5","pages":"14-15"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345974/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastroenterology and Hepatology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
